Acorah Software Products - Accounts Production 16.5.460 false true false true No description of principal activity 28 February 2024 28 February 2025 28 February 2025 15528380 Dr Nihal Tolba iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 15528380 2024-02-27 15528380 2025-02-28 15528380 2024-02-28 2025-02-28 15528380 frs-core:CurrentFinancialInstruments 2025-02-28 15528380 frs-bus:PrivateLimitedCompanyLtd 2024-02-28 2025-02-28 15528380 frs-bus:FilletedAccounts 2024-02-28 2025-02-28 15528380 frs-bus:Micro-entities 2024-02-28 2025-02-28 15528380 frs-bus:AuditExempt-NoAccountantsReport 2024-02-28 2025-02-28 15528380 frs-bus:Director1 2024-02-28 2025-02-28
Registered number: 15528380
Acute Medicine Training Ltd
Financial Statements
For The Year Ended 28 February 2025
Mibsons Limited
Chartered Certified Accountants
51 Coopers Road
Handsworth Wood
Birmingham
B20 2JU
Balance Sheet
Registered number: 15528380
2025
£
Fixed assets 8,196
Current assets 2,061
Creditors: Amounts Falling Due Within One Year (4,405 )
NET CURRENT LIABILITIES (2,344 )
TOTAL ASSETS LESS CURRENT LIABILITIES 5,852
Accruals and deferred income (900 )
NET ASSETS 4,952
CAPITAL AND RESERVES 4,952

Notes

1. General Information
Acute Medicine Training Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 15528380 . The registered office is 54 Swanswell Road, Solihull, B92 7ET.
2. Average Number of Employees
Average number of employees, including directors, during the year was: NIL
-
For the year ending 28 February 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Dr Nihal Tolba
Director
24th September 2025